Delayed-type hypersensitivity to the ultra-low-molecular-weight heparin fondaparinux.
Hohenstein
E
E
Allergy Unit, Department of Dermatology, University Hospital, Basel CH-4031, Switzerland.
Tsakiris
D
D
Bircher
A J
AJ
D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects*; D017985:Dalteparin / Q000009:adverse effects*; D017449:Dermatitis, Allergic Contact / Q000209:etiology*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D000077425:Fondaparinux; D006801:Humans; D011134:Polysaccharides / Q000009:adverse effects*; D012307:Risk Factors; D013997:Time Factors
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D011134:Polysaccharides; D000077425:Fondaparinux; D017985:Dalteparin